SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-031550
Filing Date
2023-05-22
Accepted
2023-05-22 17:51:11
Documents
1
Period of Report
2023-05-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3380
  Complete submission text file 0001209191-23-031550.txt   4828
Mailing Address 21900 BURBANK BOULEVARD 3RD FLOOR WOODLAND HILLS CA 91367
Business Address
Gengos Andrew (Reporting) CIK: 0001563623 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39503 | Film No.: 23945915

Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Issuer) CIK: 0001620463 (see all company filings)

IRS No.: 453368487 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)